Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Coll Surg ; 235(2): 306-314, 2022 08 01.
Article in English | MEDLINE | ID: mdl-35839408

ABSTRACT

BACKGROUND: Perioperative venous thromboembolism (VTE) is a significant cause of morbidity and mortality after gynecologic cancer surgery. Here we report a quality improvement intervention to increase perioperative VTE chemoprophylaxis compliance. STUDY DESIGN: All operations performed by a gynecologic oncologist at a tertiary urban university medical center admitted to the hospital for at least one midnight were included. Using a pre/post design with a washout period, we sought to increase perioperative VTE chemoprophylaxis compliance from 22% in the historical control (HC) cohort to 90% in the quality improvement (QI) cohort. The perioperative VTE chemoprophylaxis process was standardized by addressing four domains: preoperative VTE chemoprophylaxis, surgical time-out, postoperative VTE chemoprophylaxis, and intervention education and compliance tracking. Pearson's chi-square test was used to compare HC vs QI cohort compliance. RESULTS: There were 130 surgical cases in the HC cohort and 131 in the QI cohort. Forty-two percent underwent laparotomy, and 57% had cancer at the time of operation. VTE chemoprophylaxis compliance improved from 22% in the HC cohort to 82% in the QI cohort (p < 0.001). Preoperative VTE chemoprophylaxis compliance improved from 76% in the HC cohort to 94% in the QI cohort (p < 0.001), and postoperative VTE chemoprophylaxis compliance improved from 27% to 87% (p < 0.001). Thirty-day postoperative VTE occurred in three patients (2%) in the HC cohort and none in the QI cohort (p = 0.08). CONCLUSIONS: A low-cost and low-technology QI initiative intervention improved perioperative compliance with VTE chemoprophylaxis.


Subject(s)
Genital Neoplasms, Female , Venous Thromboembolism , Anticoagulants/therapeutic use , Chemoprevention/adverse effects , Cohort Studies , Female , Genital Neoplasms, Female/complications , Genital Neoplasms, Female/drug therapy , Genital Neoplasms, Female/surgery , Humans , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Quality Improvement , Retrospective Studies , Venous Thromboembolism/drug therapy , Venous Thromboembolism/etiology , Venous Thromboembolism/prevention & control
2.
J Biol Chem ; 289(51): 35530-41, 2014 Dec 19.
Article in English | MEDLINE | ID: mdl-25368328

ABSTRACT

Musashi (MSI) family proteins control cell proliferation and differentiation in many biological systems. They are overexpressed in tumors of several origins, and their expression level correlates with poor prognosis. MSI proteins control gene expression by binding RNA and regulating its translation. They contain two RNA recognition motif (RRM) domains, which recognize a defined sequence element. The relative contribution of each nucleotide to the binding affinity and specificity is unknown. We analyzed the binding specificity of three MSI family RRM domains using a quantitative fluorescence anisotropy assay. We found that the core element driving recognition is the sequence UAG. Nucleotides outside of this motif have a limited contribution to binding free energy. For mouse MSI1, recognition is determined by the first of the two RRM domains. The second RRM adds affinity but does not contribute to binding specificity. In contrast, the recognition element for Drosophila MSI is more extensive than the mouse homolog, suggesting functional divergence. The short nature of the binding determinant suggests that protein-RNA affinity alone is insufficient to drive target selection by MSI family proteins.


Subject(s)
Conserved Sequence/genetics , Nucleotide Motifs/genetics , RNA-Binding Proteins/genetics , RNA/genetics , Algorithms , Animals , Base Sequence , Binding Sites/genetics , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Fluorescence Polarization , Humans , Kinetics , Magnetic Resonance Spectroscopy , Mice , Molecular Sequence Data , Mutation , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Protein Binding , RNA/metabolism , RNA-Binding Proteins/biosynthesis , RNA-Binding Proteins/metabolism , Sequence Homology, Nucleic Acid
3.
RNA ; 19(7): 948-57, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23704325

ABSTRACT

Myelin-associated glycoprotein (MAG) is a major component of myelin in the vertebrate central nervous system. MAG is present in the periaxonal region of the myelin structure, where it interacts with neuronal proteins to inhibit axon outgrowth and protect neurons from degeneration. Two alternatively spliced isoforms of Mag mRNA have been identified. The mRNA encoding the shorter isoform, known as S-MAG, contains a termination codon in exon 12, while the mRNA encoding the longer isoform, known as L-MAG, skips exon 12 and produces a protein with a longer C-terminal region. L-MAG is required in the central nervous system. How inclusion of Mag exon 12 is regulated is not clear. In a previous study, we showed that heteronuclear ribonucleoprotein A1 (hnRNP A1) contributes to Mag exon 12 skipping. Here, we show that hnRNP A1 interacts with an element that overlaps the 5' splice site of Mag exon 12. The element has a reduced ability to interact with the U1 snRNP compared with a mutant that improves the splice site consensus. An evolutionarily conserved secondary structure is present surrounding the element. The structure modulates interaction with both hnRNP A1 and U1. Analysis of splice isoforms produced from a series of reporter constructs demonstrates that the hnRNP A1-binding site and the secondary structure both contribute to exclusion of Mag exon 12.


Subject(s)
Alternative Splicing , Heterogeneous-Nuclear Ribonucleoprotein Group A-B/metabolism , Myelin-Associated Glycoprotein/metabolism , Nucleic Acid Conformation , RNA, Messenger/metabolism , Animals , Binding Sites , Cell Line, Tumor , Exons , Heterogeneous Nuclear Ribonucleoprotein A1 , Heterogeneous-Nuclear Ribonucleoprotein Group A-B/genetics , Inverted Repeat Sequences , Mice , Myelin-Associated Glycoprotein/genetics , Protein Binding , Protein Interaction Mapping , RNA Isoforms/genetics , RNA Isoforms/metabolism , RNA Splice Sites , RNA, Messenger/genetics , Spliceosomes/genetics , Spliceosomes/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...